Cite
HARVARD Citation
Matsuoka, K. et al. (n.d.). DOP056 Efficacy and safety of anti-fractalkine monoclonal antibody, E6011, in patients with Crohn's disease who had lost response to anti-TNFα agents: A multicentre, open-label, Phase 1/2 study. Journal of Crohn's and colitis. p. S070. [Online].